Adams Alex J
Idaho State Board of Pharmacy, Boise, ID 83702, USA.
Pharmacy (Basel). 2020 Jul 8;8(3):112. doi: 10.3390/pharmacy8030112.
Pharmacist prescriptive authority continues to increase at the state level in the United States. Recently, the Idaho Board of Pharmacy (BOP) finalized regulations that expanded autonomous prescriptive authority in its state to a range of preventative care as well as acute and chronic conditions. This manuscript reviews the key decision points made by the BOP regarding drug categories included, education requirements, protocols, access to data, and use of standards of care. Overall, Idaho's approach closely reflects the medical model of regulation and may prove useful to other states and jurisdictions as they consider similar issues.
在美国，药剂师的处方权在州一级持续增加。最近，爱达荷州药剂师委员会（BOP）最终确定了相关法规，将该州的自主处方权扩大到一系列预防保健以及急性和慢性疾病领域。本文回顾了药剂师委员会在药物类别、教育要求、方案、数据获取和护理标准使用等方面做出的关键决策点。总体而言，爱达荷州的做法紧密反映了监管的医学模式，并可能对其他州和司法管辖区在考虑类似问题时有所帮助。
